Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Finance > BioNTech says collaboration with Pfizer remains unchanged

BioNTech says collaboration with Pfizer remains unchanged

Published by Global Banking and Finance Review

Posted on November 13, 2025

Featured image for article about Finance

FRANKFURT (Reuters) -BioNTech said on Thursday that its collaboration with Pfizer has not changed, when asked to comment on a report that Pfizer is looking to sell its stake in the German biotech firm.

"We continue to have a close and strong collaboration," a spokesperson said in a statement, adding that BioNTech would not be commenting on any capital market activities by Pfizer.

(Reporting by Ludwig Burger, editing by Thomas Escritt)

More from Finance

Explore more articles in the Finance category

Yen stages a partial recovery as BOJ hikes, intervention risks weighed

Oil jumps 2% as investors weigh Ukraine talks against supply outlook

North Korea's Kim Jong Un oversees cruise missile launches

Kosovo's ruling party set to win vote, exit poll shows

One dead, two missing in southern Spain as torrential rains cause flash floods

Three dead in Alawite protests on Syrian coast, local officials say

Kosovo’s Kurti promises swift formation of new government after election win

Reactions to the death of French film icon Brigitte Bardot

Amazon halts plans for drone delivery in Italy

UK and Germany sign $70 million joint deal for mobile artillery systems

Lloyds to shut invoice factoring unit by year's end, FT reports

Weak turnout seen in Myanmar's phased election, first since 2021 coup

View All Finance Posts